More rare cancers being diagnosed after the pandemic

There has been an uptick in aggressive, late-stage and rare cancers since the pandemic, and some point to COVID-19 as a possible link to the increase, The Washington Post reported June 6.

Since the 1960s, scientists have estimated that 15% to 20% of all cancers originate from infectious agents, such as HPV, Epstein-Barr and hepatitis B. It's possible that COVID-19 could be another infection that promotes cancer, but conclusive answers are not yet available.

"We are completely under-investigating this virus," Douglas Wallace, PhD, a University of Pennsylvania geneticist and evolutionary biologist, told the Post. "The effects of repeatedly getting this throughout our lives is going to be much more significant than people are thinking."

A number of small and early studies suggest COVID-19 can induce inflammatory responses that could exacerbate the growth of cancer cells. However, the virus "may be more akin to a stressor — like tobacco, alcohol, asbestos or microplastics," David Tuveson, MD, PhD, suggested in the report.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars

>